Subscribe to RSS - CGMs

CGMs

Dexcom ships G5 to Medicare beneficiaries

 - 
08/25/2017

SAN DIEGO – Dexcom has begun shipping the Dexcom G5 to Medicare beneficiaries who meet coverage requirements for continuous glucose monitoring, according to news reports. CMS in January classified “therapeutic” CGMs as DME, paving the way for coverage if certain criteria are met. In July, Dexcom reached an agreement with Ascensia Diabetes Care to bundle Ascensia’s ContourNext One glucose monitoring system with the G5. CMS has set a one-time fee of $236 to $277 for the CGM receiver, and a monthly allowable of $248.38 for related accessories. Demand for the G5 is so high that 20,000 beneficiaries are “in the pipeline” for a device. The G5 is currently the only CGM approved for insulin dosing.

CMS says CGMs cannot be used with other technology

 - 
03/30/2017

WASHINGTON – Medicare beneficiaries using Dexcom’s G5 Mobile continuous glucose monitoring system cannot use smartphone apps or tablets to display glucose data if they want to have the CGM device reimbursed, according to recently released

Diabetes in the news, in my life

 - 
Thursday, February 2, 2017

CGMs are all around me. Ads for the Dexcom G5, in particular, keep popping up on websites. I am guessing this is because I Googled it while writing a story about Medicare’s recent decision to start paying for certain CGMs (the Dexcom currently being the only one that meets the criteria at this time).

CMS approves CGMs—what now?

 - 
01/27/2017

WASHINGTON – CMS’s recent decision to classify certain continuous glucose monitoring systems as DME is a positive step, but there are a few dominoes that need to fall before they are paid for, say stakeholders.

In brief: CMS greenlights CGMs for coverage, Bain Capital makes bolt-on acquisition in pediatric market

 - 
01/20/2017

WASHINGTON – CMS classified “therapeutic” continuous glucose monitoring systems as durable medical equipment in a Jan. 12 ruling.

Tech watch: CGMs change game for diabetes

By Theresa Flaherty, Managing Editor
 - 
10/09/2015

WASHINGTON – Diabetes advocates say it’s high time for Medicare to cover continuous glucose monitors.